- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A 6-gene signature identifies four molecular subgroups of neuroblastoma ; volume:11 ; number:1 ; day:14 ; month:4 ; year:2011 ; pages:1-15 ; date:12.2011
Cancer cell international ; 11, Heft 1 (14.4.2011), 1-15, 12.2011
- Creator
-
Abel, Frida
- Contributor
-
Dalevi, Daniel
Nethander, Maria
Jörnsten, Rebecka
De Preter, Katleen
Vermeulen, Joëlle
Stallings, Raymond
Kogner, Per
Maris, John
Nilsson, Staffan
SpringerLink (Online service)
- DOI
-
10.1186/1475-2867-11-9
- URN
-
urn:nbn:de:1111-2016073017436
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Abel, Frida
- Dalevi, Daniel
- Nethander, Maria
- Jörnsten, Rebecka
- De Preter, Katleen
- Vermeulen, Joëlle
- Stallings, Raymond
- Kogner, Per
- Maris, John
- Nilsson, Staffan
- SpringerLink (Online service)
Other Objects (12)
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus
Expression Profiling Identifies Circular RNA Signature in Hepatoblastoma
Development and validation of a 21-gene prognostic signature in neuroblastoma
Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
A molecular signature in blood identifies early Parkinson's disease
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus
Expression Profiling Identifies Circular RNA Signature in Hepatoblastoma
Development and validation of a 21-gene prognostic signature in neuroblastoma
Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
A molecular signature in blood identifies early Parkinson's disease
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma
Gene expression signature of acquired chemoresistance in neuroblastoma cells
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus
Expression Profiling Identifies Circular RNA Signature in Hepatoblastoma
Development and validation of a 21-gene prognostic signature in neuroblastoma
Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups